Clear Investment Research’s Idexx Laboratories IDXX Stock Holding History

Clear Investment Research’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-25	Closed	-$13.5K	–	212
2024 Q1	$13.5K	Hold	25	–	–	0.02%	151
2023 Q4	$13.9K	Hold	25	–	–	0.02%	165
2023 Q3	$10.9K	Hold	25	–	–	0.02%	129
2023 Q2	$12.6K	Hold	25	–	–	0.02%	129
2023 Q1	$12.5K	Hold	25	–	–	0.02%	126
2022 Q4	$10K	Hold	25	–	–	0.02%	121
2022 Q3	$8K	Hold	25	–	–	0.02%	124
2022 Q2	$9K	Hold	25	–	–	0.02%	106
2022 Q1	$14K	Hold	25	–	–	0.03%	110
2021 Q4	$16K	Hold	25	–	–	0.02%	110
2021 Q3	$16K	Hold	25	–	–	0.03%	108
2021 Q2	$16K	Buy	+25	New	+$13.8K	0.03%	109

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Clear Investment Research's IDXX Position: Q2 2024 in Review

Clear Investment Research sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 25 shares — an estimated $13.5K sold.

Clear Investment Research first reported a position in IDXX in Q2 2021 and held it in 12 quarters. The position peaked at $16K in Q4 2021. 1,110 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.

Clear Investment Research reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
Clear Investment Research sold 25 Idexx Laboratories shares in Q2 2024, an estimated $13.5K.
Clear Investment Research first reported a position in Idexx Laboratories in Q2 2021 and held it in 12 quarters.
Clear Investment Research's Idexx Laboratories position peaked at $16K in Q4 2021.
1,110 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.

Based on Clear Investment Research's 13F filing for Q2 2024, filed 8 Aug 2024.